A study out of Japan found Prolia (denosumab) injection for osteoporosis may actually stop the progression of bone erosion and increase bone mineral density or BMD in patients with rheumatoid arthritis (RA) who also take methotrexate.

According to MedPage Today, study researchers note, “Addition of denosumab to background methotrexate treatment has potential to be a new therapeutic option for patients with RA with risk factors for joint destruction.”

Click here for more